NEW YORK (GenomeWeb) – Exact Sciences today announced that physicians network MDVIP will make Exact's ColoGuard colorectal cancer screening test available to its affiliated nationwide network of more than 750 primary care physicians.

In a statement, MDVIP Chief Medical Officer Andrea Klemes said that adoption of ColoGuard "will allow our patients who are 50 years and older and at average risk for colorectal cancer an easy-to-use screening test which they can do in the privacy of their own home."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.